Lead sponsor
IlDong Pharmaceutical Co Ltd
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
0
Ongoing
116
Total enrollment
20
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Trials by status
Completed
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's DiseaseAlzheimer's diseasePh 2Completed116